InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Wednesday, 12/12/2012 3:57:38 PM

Wednesday, December 12, 2012 3:57:38 PM

Post# of 130507
Who's selling .50 shares for under four cents?

Big pharma development partnership or buyout takes this to .50.

"Patience is a virtue."

The MANF comparative study will be the catalyst to start this moving seriously higher.

A very "Merry Christmas" in store for the shareholders.